Pharmaceuticals, Biotechnology and Life Sciences
PRESS RELEASE AB SCIENCE ANNOUNCES DOSING OF FIRST PATIENT IN PHASE 2 TRIAL OF MASITINIB’S ANTIVIRAL ACTIVITY AGAINST THE SARS-CoV-2…
Oslo, 29 November 2021, Carlos de Sousa, Chief Executive Officer and primary insider in Ultimovacs ASA, has today bought 1,000…
HUNTINGTON BEACH, CA, Nov. 29, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — One World Universe Inc. (OTC: OWUV), a publicly traded company…
Saint-Herblain (France) and Dessau-Roßlau (Germany), November 29, 2021 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company,…
TORONTO, Nov. 26, 2021 (GLOBE NEWSWIRE) — Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) (“Psyence” or the “Company”), a…
SOUTH SAN FRANCISCO, Nov. 26, 2021 (GLOBE NEWSWIRE) — Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients…
“Olainfarm” unaudited consolidated financial statement of the 9-month interim period of 2021 In the nine months of 2021, the Group’s…
PHILADELPHIA, Nov. 26, 2021 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC),…
MONTREAL, Nov. 26, 2021 (GLOBE NEWSWIRE) — Theratechnologies Inc. (Theratechnologies, or Company) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused…
TORONTO, Nov. 26, 2021 (GLOBE NEWSWIRE) — Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) (“Psyence” or the “Company”), a…